hVIVO plc (LON:HVO – Get Free Report) shares fell 9.3% during mid-day trading on Monday . The company traded as low as GBX 16.50 ($0.20) and last traded at GBX 16.51 ($0.20). 2,191,287 shares were traded during mid-day trading, a decline of 3% from the average session volume of 2,269,521 shares. The stock had previously closed at GBX 18.20 ($0.22).
hVIVO Stock Performance
The firm has a fifty day moving average price of GBX 21.88 and a 200 day moving average price of GBX 26.21. The company has a current ratio of 1.61, a quick ratio of 1.16 and a debt-to-equity ratio of 33.86. The firm has a market cap of £122.47 million, a PE ratio of 600.00 and a beta of 0.97.
About hVIVO
hVIVO plc operates as a pharmaceutical service and contract research company. The company is involved in testing vaccines and antivirals using human challenge clinical trials. It provides services to big pharma, biotech, government, and public health organizations. The company has a portfolio of human challenge study models for conditions, such as RSV, flu, human rhinovirus, asthma, malaria, cough, and COPD, as well as developing COVID-19 human challenge study model.
See Also
- Five stocks we like better than hVIVO
- Do ETFs Pay Dividends? What You Need to Know
- 4 Social Media Stocks Set to Gain as TikTok Ban Looms
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- How Do Stock Buybacks Affect Shareholders?
- Low PE Growth Stocks: Unlocking Investment Opportunities
- JPMorgan Chase & Co. Stock Can Hit $300 This Year
Receive News & Ratings for hVIVO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for hVIVO and related companies with MarketBeat.com's FREE daily email newsletter.
